Supporting the commercialisation of UK science and technology throughout the Covid crisis
Supporting innovation is more important than ever in these challenging times. UKI2S is investing in the UK’s most ambitious science and technology companies and is supporting startups and early stage companies throughout this crisis.
The UK has an incredibly strong research base, searching for solutions to some of the world’s most challenging issues in healthcare, such as potential treatments for COVID-19 and other diseases, as well as other industries such as ag tech, renewables, animal health, energy and security. UKI2S provides the patient capital and expertise necessary to commercialise research and build successful companies.
UKI2S remains actively investing in innovative startups. Please take a look at our investment criteria and get in touch for an initial conversation to find out more about UKI2S and how our funding could help develop your company and research. Please do include a brief summary of your company and the investment required. We will then arrange an initial video conference to get the process started.